A trial assessing Sialidase-Fc
Latest Information Update: 26 Mar 2021
At a glance
- Drugs Sialidase Fc Palleon Pharmaceuticals (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Palleon Pharmaceuticals
- 26 Mar 2021 According to a Palleon Pharmaceuticals pipeline, the IND for this study is expected in 2021 and also the trial initiation.
- 26 Mar 2021 New trial record